| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Currently in Mexico there are more than 10 million diabetics, from which only
20% is under correct control. Population growth and aging are some of the
factors that keep increasing the potential for this market. Consequently
increasingly more brands and products have been introduced into this market,
splitting the diabetes therapy business in three segments: insulin, anti
diabetes drugs and self monitoring accessories. Therefore, pharmaceutical
companies face a tough competitive environment, in order to gain public and
private healthcare sectors' share.
TABLE OF CONTENTS
1. MEXICAN MARKET INTRODUCTION AND EXECUTIVE SUMMARY
Market Introduction and Executive Summary
- Executive Summary
- Overview of the Mexican Healthcare System
- The Diabetes Business within the Mexican Pharmaceutical Market
Mexico - Diabetes Therapy Market
- Market Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
Market Forecast by Segment
- Insulin
- Antidiabetes Drugs
- Self-monitoring Accessories
Competitive Analysis and Market Share
- Insulin
- Antidiabetes Drugs
- Self-monitoring Accessories
|
